1,284
Views
0
CrossRef citations to date
0
Altmetric
Case Report

Non-ischemic cardiomyopathy with focal segmental glomerulosclerosis

ORCID Icon, , , , & ORCID Icon
Pages 154-157 | Received 11 Oct 2019, Accepted 30 Dec 2019, Published online: 21 May 2020

References

  • Braden GL, Mulhern JG, O’Shea MH, et al. Changing incidence of glomerular diseases in adults. Am J Kidney Dis. 2000;35:878–883.
  • Swaminathan S, Leung N, Lager DJ, et al. Changing incidence of glomerular disease in Olmsted County, Minnesota: a 30-year renal biopsy study. Clin J Am Soc Nephrol. 2006;1:483–487.
  • Adedoyi O, Frank R, Vento S, et al. Cardiac disease in children with primary glomerular disorders— role of focal segmental glomerulosclerosis. Pediatr Nephrol. 2004;19:408–412.
  • Chirakarnjanakorn S, Navaneethan SD, Francis GS, et al. Cardiovascular impact in patients undergoing maintenance hemodialysis: clinical management considerations. Int J Cardiol. 2017;232:12–23.
  • Lim BJ, Yang JW, Do WS, et al. Pathogenesis of focal segmental glomerulosclerosis. J Pathol Transl Med. 2016;50:405–410.
  • Chen TV, Hung CC, Tsao CJ. Hemostatic molecular markers in nephrotic syndrome. Am J Hematol. 1993;44:276–279.
  • Maron BJ, Towbin JA, Thiene G, et al. American heart association; council on clinical cardiology, heart failure and transplantation committee; quality of care and outcomes research and functional genomics and translational biology interdisciplinary working groups; and council on epidemiology and prevention. Circulation. 2006;113:1807–1816.
  • London GM, Drueke TB. Atherosclerosis and arteriosclerosis in chronic renal failure. Kidney Int. 2002;73:678–1695.
  • London GM, Marchais SJ, Guerin AP. Arterial stiffness and function in end-stage renal disease. Adv Chron Kidney Dis. 2004;11: 202–209.
  • de Jager DJ, Grootendorst DC, Jager KJ, et al. Cardiovascular and noncardiovascular mortality among patients starting dialysis. JAMA. 2009;302:1782–1789.
  • Wada T, Nangaku M. A circulating permeability factor in focal segmental glomerulosclerosis: the hunt continues. Clin Kidney J. 2015;8:708–715.
  • Vincenti F, Ghiggeri GM. New insights into the pathogenesis and the therapy of recurrent focal glomerulosclerosis. Am J Transplant. 2005;5:1179–1185.
  • Davenport RD. Apheresis treatment of recurrent focal segmental glomerulosclerosis after kidney transplantation: re-analysis of published case-reports and case-series. J Clin Apher. 2001;16:175–178.
  • Sharma M, Sharma R, Reddy SR, et al. Proteinuria after injection of human focal segmental glomerulosclerosis factor. Transplantation. 2002;73:366–372.
  • Kemper MJ, Wolf G, Muller-Wiefel DE. Transmission of glomerular permeability factor from a mother to her child. N Engl J Med. 2001;344:386–387.
  • Han KH, Park JY, Min SK, et al. Bilateral iliac and popliteal arterial thrombosis in a child with focal segmental glomerulosclerosis. Korean J Pediatr. 2016;59(5):242–245.
  • Guenther RA, Kemp WL. Delayed death due to saddle pulmonary thromboembolus in child with nephrotic syndrome induced by focal segmental glomerulosclerosis. Am J Forensic Med Pathol. 2018;39(4):370.